UNRESECTABLE COLORECTAL CANCER
Clinical trials for UNRESECTABLE COLORECTAL CANCER explained in plain language.
Never miss a new study
Get alerted when new UNRESECTABLE COLORECTAL CANCER trials appear
Sign up with your email to follow new studies for UNRESECTABLE COLORECTAL CANCER, keep track of the ones that matter, and come back to a personal dashboard instead of checking manually.
By submitting, you agree to our Terms of use
-
Engineered immune cells take aim at Hard-to-Treat colorectal cancer
Disease control Recruiting nowThis early-stage trial tests a new type of immune cell therapy (CAR-NK cells) in people with advanced colorectal cancer that has not responded to standard treatments. The cells are designed to target two cancer-related proteins at once, based on each patient's tumor markers. The …
Matched conditions: UNRESECTABLE COLORECTAL CANCER
Phase: PHASE1, PHASE2 • Sponsor: Beijing Biotech • Aim: Disease control
Last updated Jun 27, 2026 12:33 UTC
-
New chemo delivery method aims to shrink untreatable colon tumors
Disease control Recruiting nowThis study tests a procedure called transarterial infusion chemotherapy (TAIC) for people with colorectal cancer that cannot be removed by surgery. Instead of giving chemo through a vein, TAIC delivers it directly to the tumor's blood supply, which may boost effectiveness and red…
Matched conditions: UNRESECTABLE COLORECTAL CANCER
Phase: NA • Sponsor: Quanda Liu • Aim: Disease control
Last updated Jun 27, 2026 09:10 UTC